Refer to the Department of Neurology’s clinical trial page for a comprehensive listing.
About participating
What is a clinical trial? Clinical trials are organized experiments performed on human participants to determine the best way to treat, diagnose or prevent a disease. The information that scientists learn from clinical trials helps to improve the medical care for future patients. Clinical studies are carefully and ethically designed to protect participants from unnecessary side effects and other risks. Most clinical research is federally regulated with built-in safeguards to protect the participants.
- Conditions: Active Idiopathic Inflammatory Myopathy; Myositis; Dermatomyositis; Polymyositis; Immune-Mediated Necrotizing Myopathy; Antisynthetase Syndrome Interventions: Biological: EFG PH20 SC; Other: PBO Sponsors: argenx Recruiting
- Conditions: Myositis Interventions: Drug: PF-06823859; Drug: Placebo Sponsors: Pfizer Recruiting
- Conditions: Rheumatoid Arthritis (RA); Systemic Lupus Erythematosus (SLE); Pemphigus Vulgaris; Multiple Sclerosis (MS); Systemic Sclerosis (SSc); Pediatric SLE; Juvenile Idiopathic Arthritis (JIA); Juvenile Dermatomyositis (JDM); Pediatric-Onset Multiple Sclerosis (POMS) Interventions: Biological: Moderna mRNA-1273; Biological: BNT162b2; Biological: Ad26.COV2.S; Drug: Continue IS (MMF or MPA); Drug: Continue IS (MTX); Biological: Continue IS (B cell depletion therapy); Biological: Monovalent [B.1.351] CoV2 preS dTM-AS03; Drug: Withhold IS (MMF or MPA); Drug: Withhold IS (MTX); Drug: Withhold IS (B cell depletion therapy); Biological: Moderna mRNA-1273, Bivalent; Biological: BNT162b2, Bivalent Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Autoimmunity Centers of Excellence; Rho Federal Systems […]
- Conditions: Sporadic Inclusion Body Myositis; Inclusion Body Myositis Sponsors: University of California, Irvine; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Active, not recruiting
- Conditions: Duchenne Muscular Dystrophy Interventions: Drug: Pamrevlumab Sponsors: FibroGen Terminated
- Conditions: Muscular Dystrophy, Duchenne Interventions: Genetic: delandistrogene moxeparvovec Sponsors: Sarepta Therapeutics, Inc.; Hoffmann-La Roche Active, not recruiting
- Conditions: Amyotrophic Lateral Sclerosis Sponsors: St. Joseph's Hospital and Medical Center, Phoenix; Massachusetts General Hospital; National Institute of Neurological Disorders and Stroke (NINDS); Foundation for the National Institutes of Health Recruiting
- Conditions: Amyotrophic Lateral Sclerosis Interventions: Drug: Reldesemtiv; Drug: Placebo Sponsors: Cytokinetics Terminated
- Conditions: Amyotrophic Lateral Sclerosis Sponsors: St. Joseph's Hospital and Medical Center, Phoenix; Massachusetts General Hospital; National Institute of Neurological Disorders and Stroke (NINDS); Foundation for the National Institutes of Health Recruiting
- Conditions: Amyotrophic Lateral Sclerosis Interventions: Drug: ION363; Drug: Placebo Sponsors: Ionis Pharmaceuticals, Inc. Recruiting
- Conditions: Amyotrophic Lateral Sclerosis, Familial; Amyotrophic Lateral Sclerosis, Sporadic Sponsors: Washington University School of Medicine; Massachusetts General Hospital Suspended
- Conditions: Sporadic Inclusion Body Myositis; Inclusion Body Myositis Sponsors: University of California, Irvine; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Active, not recruiting